Qiagen (NYSE:QGEN) Earns Overweight Rating from Analysts at Barclays
Stock analysts at Barclays began coverage on shares of Qiagen (NYSE:QGEN – Get Free Report) in a research note issued on Tuesday, MarketBeat Ratings reports. The firm set an “overweight” rating and a $55.00 price target on the stock. Barclays‘s price objective would indicate a potential upside of 15.84% from the stock’s current price. A […]
Stock analysts at Barclays began coverage on shares of Qiagen (NYSE:QGEN – Get Free Report) in a research note issued on Tuesday, MarketBeat Ratings reports. The firm set an “overweight” rating and a $55.00 price target on the stock. Barclays‘s price objective would indicate a potential upside of 15.84% from the stock’s current price. A […]
